Clinical trial recruitment is a challenging step toward FDA approval of new treatments for patients across...
Since most of the microbes in our gut are bacteria, they tend to hog much of...
In an upcoming study to be published in Gastroenterology, scientists at the Icahn School of Medicine...
The introduction of infliximab (Remicade), the first biologic therapy approved for the treatment of inflammatory bowel...